Cargando…
New therapeutic options opened by the molecular classification of gastric cancer
Gastric cancer (GC) is one of the most lethal and aggressive cancers, being the third cause of cancer related death worldwide. Even with radical gastrectomy and the latest generation of molecular chemotherapeutics, the numbers of recurrence and mortality remains high. This is due to its biological h...
Autores principales: | Chivu-Economescu, Mihaela, Matei, Lilia, Necula, Laura G, Dragu, Denisa L, Bleotu, Coralia, Diaconu, Carmen C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5949709/ https://www.ncbi.nlm.nih.gov/pubmed/29760539 http://dx.doi.org/10.3748/wjg.v24.i18.1942 |
Ejemplares similares
-
Clinical Applications of Liquid Biopsy in Gastric Cancer
por: Chivu-Economescu, Mihaela, et al.
Publicado: (2021) -
Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer
por: Necula, Laura, et al.
Publicado: (2022) -
Recent advances in gastric cancer early diagnosis
por: Necula, Laura, et al.
Publicado: (2019) -
Murine models based on acute myeloid leukemia-initiating stem cells xenografting
por: Mambet, Cristina, et al.
Publicado: (2018) -
High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients
por: Necula, Laura, et al.
Publicado: (2020)